Craig Joseph Thomas, Ph.D.
Affiliations: | 1995-2000 | Chemistry | Syracuse University, Syracuse, NY, United States |
Area:
studies of thermal stereomutations of cyclopropanes, structural isomerizations of vinylcyclopropanes to cyclopentenes and vinylcyclobutanes to cyclohexenes, and degenerate isomerizations of cycloalka-1,3-dienesWebsite:
https://www.proquest.com/docview/304663366/Google:
"Craig Thomas"Mean distance: 8.37 | S | N | B | C | P |
Parents
Sign in to add mentor| John E. Baldwin | grad student | 1995-2000 | Syracuse | |
| (co-advisor) | ||||
| Watson James Lees | grad student | 1995-2000 | Syracuse | |
| (Design and synthesis of fluorinated derivatives of indolyl fulgides and fulgimides.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Itkonen HM, Poulose N, Steele RE, et al. (2020) Inhibition of O-GlcNAc transferase renders prostate cancer cells dependent on CDK9. Molecular Cancer Research : McR |
| Harrington BS, Ozaki MK, Caminear MW, et al. (2020) Drugs Targeting Tumor-Initiating Cells Prolong Survival in a Post-Surgery, Post-Chemotherapy Ovarian Cancer Relapse Model. Cancers. 12 |
| Issaq SH, Mendoza A, Kidner R, et al. (2020) EWS-FLI1-regulated serine synthesis and exogenous serine are necessary for Ewing sarcoma cellular proliferation and tumor growth. Molecular Cancer Therapeutics |
| Wei D, Yang Y, Ricketts CJ, et al. (2020) Novel renal medullary carcinoma cell lines, UOK353 and UOK360, provide preclinical tools to identify new therapeutic treatments. Genes, Chromosomes & Cancer |
| Burgess TL, Amason JD, Rubin JS, et al. (2020) A homogeneous SIRPα-CD47 cell-based, ligand-binding assay: Utility for small molecule drug development in immuno-oncology. Plos One. 15: e0226661 |
| Jones LM, Melgar K, Bolanos L, et al. (2020) Targeting AML-associated FLT3 mutations with a type I kinase inhibitor. The Journal of Clinical Investigation |
| Yohe ME, Gryder BE, Chou H, et al. (2020) Abstract B17: MEK inhibition induces myogenic differentiation in RAS-driven rhabdomyosarcoma Molecular Cancer Research. 18 |
| Bondesson AJ, Miyaki A, Shin S, et al. (2020) Abstract B32: High-throughput chemical screening reveals YAP-mediated alterations in drug sensitivities Molecular Cancer Research. 18 |
| Ceribelli M, Morris P, Duveau D, et al. (2020) Abstract B06: Development of selective LATS1/LATS2 inhibitors for the pharmacologic modulation of the Hippo signaling pathway Molecular Cancer Research. 18 |
| Issaq S, Mendoza A, Rosales T, et al. (2020) Abstract 5714: Targeting serine metabolism impairs tumor growth in preclinical models of Ewing sarcoma Cancer Research. 80: 5714-5714 |